According to this statement, the conglomerate pharmaceutical company ViiV & Janssen are co-filing an application with the FDA for approval of a once-monthly, injectable regimen. The injection is composed of a medication from each parent company. This means they are in final stages of development.
This could soon be a reality for people living with HIV. Moves like this could change the way HIV is handled. A single, periodic injection would be much to maintain than a daily regimen. It would require the patient to see a medical professional. They could be better monitored. This seems like a win.
Cya...
No comments:
Post a Comment